Viewing Study NCT00584961


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2025-12-27 @ 9:10 PM
Study NCT ID: NCT00584961
Status: COMPLETED
Last Update Posted: 2021-02-21
First Post: 2007-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A1281161
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators